The medication promotes natriuresis (sodium excretion through urine), which reduces intravascular volume your blood volume decreases as excess fluid is eliminated
It is also being studied for its potential to slow the progression of neurodegenerative diseases like Alzheimer's
TB-500 (Thymosin Beta-4) Phase I and Phase II safety trials of intravenous thymosin beta-4 published in human cohorts (Ruff et al., 2010)
For researchers following the GLP-1 and immune system connection , this IL-6 link is particularly interesting
Haenssle HA, Mograby N, Ngassa A, Buhl T, Emmert S, Schon MP et al
RELATED: How to save on Trulicity The SingleCare prices in this article are the most accurate at the time of publishing in ZIP code 23666 as of Jun